Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematologic NeoplasmsStem Cell TransplantationHematopoietic Stem Cell MobilizationHematopoietic Stem CellsCombined Modality TherapyMelphalanMyeloablative AgonistsAntigens, CD34Granulocyte Colony-Stimulating FactorBusulfanTreatment OutcomeBone Marrow TransplantationLeukapheresisGraft SurvivalMultiple MyelomaCyclophosphamideBlood Component RemovalTransplantation ChimeraRecurrenceAntineoplastic Combined Chemotherapy ProtocolsTissue DonorsRemission InductionGraft vs Leukemia EffectStem CellsRetrospective StudiesLymphoma, Non-HodgkinCord Blood Stem Cell TransplantationHistocompatibilityWhole-Body IrradiationHistocompatibility TestingSalvage TherapyEtoposideThiotepaAntineoplastic Agents, AlkylatingLeukemiaDisease-Free SurvivalVidarabineSurvival RateHematopoiesisLeukemia, Myeloid, AcuteImmunosuppressive AgentsSurvival AnalysisTime FactorsGraft vs Tumor EffectCytarabineCarmustineHematologic DiseasesMyelodysplastic SyndromesCytophagocytosisCytomegalovirus InfectionsChimerismTransplantation, IsogeneicVincristineIfosfamideHodgkin DiseaseHLA AntigensAmyloidosisFollow-Up StudiesNeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaSiblingsLymphocyte TransfusionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticAllograftsInfectionLymphocyte DepletionT-LymphocytesOpportunistic InfectionsFatal OutcomeTransplantation ImmunologyHepatic Veno-Occlusive DiseaseAcute DiseaseLiver TransplantationProspective StudiesAntineoplastic AgentsLymphoma, T-CellFlow CytometryPlatelet CountNeoplasm, ResidualDoxorubicinPrognosisPrednisoneImmunosuppressionBlood Cell CountPOEMS SyndromeMesenchymal Stem Cell TransplantationAntilymphocyte SerumCyclosporineBlood Group IncompatibilityBone Marrow CellsLymphomaBlood CellsDexamethasone